WuXi Biologics (Cayman) Inc (WXXWY)
4.39
-0.14
(-3.09%)
USD |
OTCM |
Dec 16, 15:58
WuXi Biologics Enterprise Value: 8.840B for Dec. 13, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Zai Lab Ltd | 2.326B |
| Sinovac Biotech Ltd | -6.942B |
| CASI Pharmaceuticals Inc | 46.39M |
| Adagene Inc | 16.06M |
| LakeShore Biopharma Co Ltd | -- |
Enterprise Value Related Metrics
| Earnings Yield | 3.80% |
| Operating Earnings Yield | 5.96% |
| Normalized Earnings Yield | 3.930 |